Statistical issues in drug development /
| Main Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Chichester ; New York :
John Wiley,
©1997.
|
| Series: | Statistics in practice.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Part I: Four views of statistics in drug development: historical, methodological, technical and professional
- A brief and superficial history of statistics for drug developers
- Design and interpretation of clinical trials as seen by a statistician
- Probability, bayes, p-values, test of hypotheses and confidence intervals
- The work of the pharmaceutical statistician
- Part II: Statistical issues: debatable and controvertsial topics in drug development
- Allocating treatments to patients in clinical trials
- Baselines and covariate information
- The measurement of treatment effects
- Demographic sub-groups: representation and analysis
- Multiplicity
- Intention to treat
- One-sided and two-sided tests
- Determining the sample size
- Multi-centre trials
- Active control equivalence studies
- Meta-analysis
- Cross-over trials
- N-of-1 trials
- Sequential trials
- Dose-finding
- Concerning pharmacokinetics and pharmacodynamics
- Bioequivalence studies
- Safety data, drug monitoring and pharmaco-epidemiology
- Pharmaco-economics and portfolio management.